Salyka Sengsayadeth

1.1k total citations
41 papers, 502 citations indexed

About

Salyka Sengsayadeth is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Salyka Sengsayadeth has authored 41 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 20 papers in Oncology and 13 papers in Immunology. Recurrent topics in Salyka Sengsayadeth's work include Hematopoietic Stem Cell Transplantation (18 papers), CAR-T cell therapy research (14 papers) and Acute Myeloid Leukemia Research (7 papers). Salyka Sengsayadeth is often cited by papers focused on Hematopoietic Stem Cell Transplantation (18 papers), CAR-T cell therapy research (14 papers) and Acute Myeloid Leukemia Research (7 papers). Salyka Sengsayadeth collaborates with scholars based in United States, France and Germany. Salyka Sengsayadeth's co-authors include Bipin N. Savani, Bhagirathbhai Dholaria, Olalekan O. Oluwole, Madan Jagasia, Adetola A. Kassim, Stacey Goodman, John L. Abernathy, Brian G. Engelhardt, John P. Greer and Wichai Chinratanalab and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Salyka Sengsayadeth

32 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salyka Sengsayadeth United States 13 257 256 148 140 61 41 502
Houston Holmes United States 12 319 1.2× 202 0.8× 88 0.6× 119 0.8× 45 0.7× 39 540
Linghui Xia China 11 209 0.8× 287 1.1× 82 0.6× 99 0.7× 27 0.4× 26 455
Martín Bonamino Brazil 12 233 0.9× 100 0.4× 139 0.9× 171 1.2× 32 0.5× 27 460
Folashade Otegbeye United States 10 316 1.2× 135 0.5× 126 0.9× 239 1.7× 48 0.8× 57 517
Xing-Mei Cao China 11 218 0.8× 179 0.7× 191 1.3× 188 1.3× 37 0.6× 33 509
Alberto Mussetti Spain 13 251 1.0× 196 0.8× 96 0.6× 97 0.7× 23 0.4× 51 435
Xiaming Zhu China 11 490 1.9× 224 0.9× 131 0.9× 343 2.5× 60 1.0× 42 677
Carrie Yuen United States 7 284 1.1× 77 0.3× 163 1.1× 123 0.9× 70 1.1× 19 470
Xia Mao China 16 512 2.0× 194 0.8× 235 1.6× 180 1.3× 104 1.7× 66 741
Sujun Gao China 13 192 0.7× 355 1.4× 133 0.9× 216 1.5× 24 0.4× 38 613

Countries citing papers authored by Salyka Sengsayadeth

Since Specialization
Citations

This map shows the geographic impact of Salyka Sengsayadeth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salyka Sengsayadeth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salyka Sengsayadeth more than expected).

Fields of papers citing papers by Salyka Sengsayadeth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salyka Sengsayadeth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salyka Sengsayadeth. The network helps show where Salyka Sengsayadeth may publish in the future.

Co-authorship network of co-authors of Salyka Sengsayadeth

This figure shows the co-authorship network connecting the top 25 collaborators of Salyka Sengsayadeth. A scholar is included among the top collaborators of Salyka Sengsayadeth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salyka Sengsayadeth. Salyka Sengsayadeth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jayani, Reena, Andrew Jallouk, James H. Jerkins, et al.. (2025). Impact of Granulocyte Colony Stimulating Factor Use Following CD-19 Chimeric Antigen Receptor T-Cell Therapy. Transplantation and Cellular Therapy. 32(1). 48–58. 1 indexed citations
2.
Dholaria, Bhagirathbhai, Shakthi Bhaskar, Reena Jayani, et al.. (2025). Feasibility of axicabtagene ciloleucel in the outpatient setting: primary analysis of prospective trial. Bone Marrow Transplantation. 60(6). 769–772.
3.
Park, Silvia, Rahul Shah, Carlos Prieto‐Granada, et al.. (2024). GVHD like skin eruption post-autologous stem cell transplantation. Bone Marrow Transplantation. 59(6). 900–903.
4.
Gilmore, R.M., Adetola A. Kassim, Salyka Sengsayadeth, et al.. (2024). Efficacy and safety of outpatient fludarabine, cyclophosphamide, and rituximab based allogeneic hematopoietic cell transplantation in adults with severe aplastic anemia. Bone Marrow Transplantation. 59(9). 1275–1279.
5.
Bhaskar, Shakthi, Bhagirathbhai Dholaria, Bipin N. Savani, Salyka Sengsayadeth, & Olalekan O. Oluwole. (2024). Overview of approved CAR-T products and utility in clinical practice. PubMed. 6(4). 93–99. 12 indexed citations
6.
Jayani, Reena, Adetola A. Kassim, Bipin N. Savani, et al.. (2024). Outcomes of Hematopoietic Stem Cell Transplantation in Patients Aged 70 Years and Older. Blood. 144(Supplement 1). 5172–5172.
7.
Jallouk, Andrew, Salyka Sengsayadeth, Bipin N. Savani, Bhagirathbhai Dholaria, & Olalekan O. Oluwole. (2024). Allogeneic and other innovative chimeric antigen receptor platforms. PubMed. 6(3). 61–72. 2 indexed citations
8.
Chen, Heidi, Deva Sharma, Michael Byrne, et al.. (2022). Reduction in the Prevalence of Thrombotic Events in Sickle Cell Disease after Allogeneic Hematopoietic Transplantation. Transplantation and Cellular Therapy. 28(5). 277.e1–277.e6. 3 indexed citations
9.
Abernathy, John L., et al.. (2021). CAR T cell therapy in solid tumors: A review of current clinical trials. SHILAP Revista de lepidopterología. 3(S1). 24–31. 87 indexed citations
10.
Rao, Uttam K., Heidi Chen, Katie S. Gatwood, et al.. (2020). Reduced Insulin Sensitivity in Patients with Myeloid Malignancies and Clonal Hematopoiesis Mutations. Blood. 136(Supplement 1). 27–28. 1 indexed citations
11.
Byrne, Michael, Salyka Sengsayadeth, Katie S. Gatwood, et al.. (2020). The use of venetoclax‐based salvage therapy for post‐hematopoietic cell transplantation relapse of acute myeloid leukemia. American Journal of Hematology. 95(9). 1006–1014. 44 indexed citations
12.
Phillips, Sharon, Michael Byrne, Wichai Chinratanalab, et al.. (2018). Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma. Bone Marrow Transplantation. 53(6). 701–707. 13 indexed citations
13.
Kennedy, Vanessa E., Heidi Chen, Bipin N. Savani, et al.. (2017). Optimizing Antithymocyte Globulin Dosing for Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Based on Recipient Absolute Lymphocyte Count. Biology of Blood and Marrow Transplantation. 24(1). 150–155. 47 indexed citations
14.
Kennedy, Vanessa E., Bipin N. Savani, John P. Greer, et al.. (2016). Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies. Biology of Blood and Marrow Transplantation. 22(10). 1801–1807. 7 indexed citations
15.
Li, Zhuoyan, Samuel M. Rubinstein, Michael Byrne, et al.. (2016). Yearly Long-Acting Zoledronic Acid (Reclast) Is Safe and Effective for Treatment of Bone Loss after Hematopoietic Stem Cell Transplantation. Blood. 128(22). 3438–3438.
16.
Sengsayadeth, Salyka, Bipin N. Savani, Didier Blaise, & Mohamad Mohty. (2016). Haploidentical transplantation: selecting optimal conditioning regimen and stem cell source. Seminars in Hematology. 53(2). 111–114. 13 indexed citations
17.
Vu, Mary, Salyka Sengsayadeth, David Hagaman, et al.. (2013). New allergies after cord blood transplantation. Cytotherapy. 15(10). 1259–1265. 2 indexed citations
18.
Engelhardt, Brian G., Salyka Sengsayadeth, Madan Jagasia, et al.. (2012). Tissue-specific regulatory T cells: biomarker for acute graft-vs-host disease and survival. Experimental Hematology. 40(12). 974–982.e1. 14 indexed citations
19.
Sengsayadeth, Salyka, Madan Jagasia, Barbara Engelhardt, et al.. (2012). Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers. Bone Marrow Transplantation. 47(12). 1535–1537. 51 indexed citations
20.
Sengsayadeth, Salyka, Shivani Srivastava, Madan Jagasia, & Bipin N. Savani. (2012). Time to Explore Preventive and Novel Therapies for Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 18(10). 1479–1487. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Houston Holmes Breakdown of academic impact, for papers by Linghui Xia Breakdown of academic impact, for papers by Martín Bonamino Breakdown of academic impact, for papers by Folashade Otegbeye Breakdown of academic impact, for papers by Xing-Mei Cao Breakdown of academic impact, for papers by Alberto Mussetti Breakdown of academic impact, for papers by Xiaming Zhu Breakdown of academic impact, for papers by Carrie Yuen Breakdown of academic impact, for papers by Xia Mao Breakdown of academic impact, for papers by Sujun Gao
Rankless by CCL
2026